Diffusion-weighted imaging and magnetic resonance spectroscopy of sporadic Creutzfeldt-Jakob disease: correlation with clinical course

被引:23
作者
Kim, Jae Hyoung [2 ]
Choi, Byung Se [2 ]
Jung, Cheolkyu [2 ]
Chang, YoungHee [1 ]
Kim, SangYun [1 ]
机构
[1] Seoul Natl Univ, Dept Neurol, Coll Med, Bundang Hosp, Songnam 463707, South Korea
[2] Seoul Natl Univ, Dept Radiol, Coll Med, Bundang Hosp, Songnam 463707, South Korea
关键词
Sporadic Creutzfeldt-Jakob disease; Spectroscopy; Diffusion-weighted imaging; Clinical course; MRI; DIAGNOSIS;
D O I
10.1007/s00234-010-0820-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Sporadic Creutzfeldt-Jakob disease (sCJD) is a fatal disease with variable clinical courses. The presence or absence of basal ganglia (BG) involvement has been reported to be associated with clinical course. We investigated the association of clinical course of sCJD with diffusion-weighted imaging (DWI) and MR spectroscopy (MRS) as well as BG involvement at early stage. DWI and single voxel proton MRS were performed in 14 patients with sCJD during the initial diagnostic workup. Apparent diffusion coefficient (ADC) and metabolites were measured in medial occipitoparietal cortices where large hyperintense DWI lesions were found in all patients. The presence or absence of BG involvement, ADC, N-acetylaspartate (NAA)/creatine (Cr) ratios, and choline (Cho)/Cr ratios were correlated with disease duration (i.e., the time from the symptom onset to death). The disease duration ranged from 2 to 31 months (median, 16). Hyperintense DWI lesions were observed bilaterally in both cortices and basal ganglia in eight patients and in cortices alone in six patients. Patients with BG involvement had shorter disease duration (median, 6.8 versus 20.5; p = 0.039) than those without and lower NAA/Cr ratios (median, 1.41 versus 2.03; p = 0.001). ADC and Cho/Cr ratios were not significantly different between the patients with BG involvement and those without. By multiple regression analysis, NAA/Cr ratios had the greatest correlation with the disease duration (p = 0.029). The disease duration of sCJD was variable. NAA/Cr ratios of the affected brain at the early stage of sCJD can be used as a useful parameter in predicting the clinical course.
引用
收藏
页码:939 / 945
页数:7
相关论文
共 23 条
[1]   INVIVO MONITORING OF NEURONAL LOSS IN CREUTZFELDT-JAKOB DISEASE BY PROTON MAGNETIC-RESONANCE SPECTROSCOPY [J].
BRUHN, H ;
WEBER, T ;
THORWIRTH, V ;
FRAHM, J .
LANCET, 1991, 337 (8757) :1610-1611
[2]   Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease [J].
Demaerel, P ;
Heiner, L ;
Robberecht, W ;
Sciot, R ;
Wilms, G .
NEUROLOGY, 1999, 52 (01) :205-208
[3]   Accuracy of diffusion-weighted MR imaging in the diagnosis of sporadic Creutzfeldt-Jakob disease [J].
Demaerel, P ;
Sciot, R ;
Robberecht, W ;
Dom, R ;
Vandermeulen, D ;
Maes, F ;
Wilms, G .
JOURNAL OF NEUROLOGY, 2003, 250 (02) :222-225
[4]   Combined Diffusion Imaging and MR Spectroscopy in the Diagnosis of Human Prion Diseases [J].
Galanaud, D. ;
Haik, S. ;
Linguraru, M. G. ;
Ranjeva, J. -P. ;
Faucheux, B. ;
Kaphan, E. ;
Ayache, N. ;
Chiras, J. ;
Cozzone, P. ;
Dormont, D. ;
Brandel, J. -P. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2010, 31 (07) :1311-1318
[5]   PROTON MAGNETIC-RESONANCE SPECTROSCOPY IN CREUTZFELDT-JAKOB-DISEASE [J].
GRAHAM, GD ;
PETROFF, OAC ;
BLAMIRE, AM ;
RAJKOWSKA, G ;
GOLDMANRAKIC, P ;
PRICHARD, JW .
NEUROLOGY, 1993, 43 (10) :2065-2068
[6]  
Kim JP, 2005, AM J NEURORADIOL, V26, P752
[7]   Combined diffusion-weighted and spectroscopic MR imaging in Creutzfeldt-Jakob disease [J].
Lim, CCT ;
Tan, K ;
Verma, KK ;
Yin, H ;
Venketasubramanian, N .
MAGNETIC RESONANCE IMAGING, 2004, 22 (05) :625-629
[8]   SUB-ACUTE SPONGIFORM ENCEPHALOPATHY (CREUTZFELDT-JAKOB DISEASE) - NATURE AND PROGRESSION OF SPONGIFORM CHANGE [J].
MASTERS, CL ;
RICHARDSON, EP .
BRAIN, 1978, 101 (JUN) :333-344
[9]   Creutzfeldt-Jakob disease: Serial changes on diffusion-weighted MRI [J].
Matoba, M ;
Tonami, H ;
Miyaji, H ;
Yokota, H ;
Yamamoto, I .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2001, 25 (02) :274-277
[10]  
Matsusue E, 2004, AM J NEURORADIOL, V25, P910